Eric Morgen compensation by year
BioAge Labs Summary Compensation Table · all 2 fiscal years held| Component | FY2024 | FY2025 |
|---|---|---|
| Salary | $457,657 | $499,600 |
| Bonus | $0 | $0 |
| Stock awards | $0 | $0 |
| Option awards | $1,832,510 | $732,600 |
| Non-equity incentive | $160,180 | $199,840 |
| Pension and deferred compensation | $0 | $0 |
| All other | $15,000 | $15,200 |
| Total | $2,465,347 | $1,447,240 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BioAge Labs, Inc. DEF 14A filed April 21, 2026, accession 0001193125-26-166738, and prior-year filings.
How this page was built: the BioAge Labs, Inc. filed document, accession 0001193125-26-166738. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 2,680 | — | $6.57 |
| Option | 13,396 | — | $10.85 |
| Option | 150,485 | — | $8.39 |
| Option | 154,167 | — | $4.38 |
Per the Outstanding Equity Awards at Fiscal Year-End table in BioAge Labs, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
BioAge Labs’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Kristen Fortney | Chief Executive Officer and President | $2,886,590 |
| Paul Rubin | Chief Medical Officer | $1,476,080 |
| Eric Morgen · this page | Chief Operating Officer | $1,447,240 |
Board service
BioAge Labs board · FY2025How this board is paid
Company policy: BioAge Labs pays directors a $40,000 cash retainer. As stated in BioAge Labs's FY2025 proxy.
Eric Morgen's compensation dossier, BioAge Labs
You have read Eric Morgen's totals and holdings. The dossier adds each equity grant BioAge Labs disclosed for Eric Morgen and BioAge Labs's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full BioAge Labs compensation record
free company briefThis page is one person within BioAge Labs's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order BioAge Labs's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BioAge Labs's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.